79 related articles for article (PubMed ID: 19522833)
41. Double trouble for type 1 angiotensin receptors in atherosclerosis.
Thomas WG
N Engl J Med; 2005 Feb; 352(5):506-8. PubMed ID: 15689592
[No Abstract] [Full Text] [Related]
42. Triple twist theory of rho inhibition by the angiotensin II type 2 receptor.
Eguchi S
Circ Res; 2008 May; 102(10):1143-5. PubMed ID: 18497311
[No Abstract] [Full Text] [Related]
43. Specific binding of 3H-angiotensin II in rabbit aorta.
Baudouin M; Meyer P; Worcel M
Biochem Biophys Res Commun; 1971 Feb; 42(3):434-40. PubMed ID: 4322548
[No Abstract] [Full Text] [Related]
44. [Correlation between angiotensin II level and severity of liver cirrhosis].
Fang DQ; Guo J; Chen YF; Shi D; Li LJ
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):794-796. PubMed ID: 27938569
[No Abstract] [Full Text] [Related]
45. The Calcium Content of Arteriosclerotic Aortas: Series II.
Haythorn SR; Taylor FA
Am J Pathol; 1936 May; 12(3):303-15. PubMed ID: 19970268
[No Abstract] [Full Text] [Related]
46. Correction to: Angiotensin-(1-7) and Vascular Function: The Clinical Context.
Hypertension; 2018 Mar; 71(3):e9. PubMed ID: 29440287
[No Abstract] [Full Text] [Related]
47. Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
Sauerbruch T; Hennenberg M; Trebicka J; Schierwagen R
Front Med (Lausanne); 2022; 9():1100966. PubMed ID: 36743678
[TBL] [Abstract][Full Text] [Related]
48. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction.
Sauerbruch T; Hennenberg M; Trebicka J; Beuers U
Front Physiol; 2021; 12():718783. PubMed ID: 34393832
[TBL] [Abstract][Full Text] [Related]
49. Maternal microvascular dysfunction during preeclamptic pregnancy.
Stanhewicz AE; Nuckols VR; Pierce GL
Clin Sci (Lond); 2021 May; 135(9):1083-1101. PubMed ID: 33960392
[TBL] [Abstract][Full Text] [Related]
50. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
[TBL] [Abstract][Full Text] [Related]
51. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Gunarathne LS; Rajapaksha H; Shackel N; Angus PW; Herath CB
World J Gastroenterol; 2020 Oct; 26(40):6111-6140. PubMed ID: 33177789
[TBL] [Abstract][Full Text] [Related]
52. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
[TBL] [Abstract][Full Text] [Related]
53. The emerging roles of β-arrestins in fibrotic diseases.
Gu YJ; Sun WY; Zhang S; Wu JJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1277-87. PubMed ID: 26388156
[TBL] [Abstract][Full Text] [Related]
54. ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
Mak KY; Chin R; Cunningham SC; Habib MR; Torresi J; Sharland AF; Alexander IE; Angus PW; Herath CB
Mol Ther; 2015 Sep; 23(9):1434-43. PubMed ID: 25997428
[TBL] [Abstract][Full Text] [Related]
55. Murine study of portal hypertension associated endothelin-1 hypo-response.
Theodorakis N; Maluccio M; Skill N
World J Gastroenterol; 2015 Apr; 21(16):4817-28. PubMed ID: 25944995
[TBL] [Abstract][Full Text] [Related]
56. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
Iwakiri Y; Shah V; Rockey DC
J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
[TBL] [Abstract][Full Text] [Related]
57. Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.
Chen W; Liu DJ; Huo YM; Wu ZY; Sun YW
Int J Biol Sci; 2014; 10(4):386-95. PubMed ID: 24719556
[TBL] [Abstract][Full Text] [Related]
58. Pathophysiology of portal hypertension.
Iwakiri Y
Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
[TBL] [Abstract][Full Text] [Related]
59. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
[TBL] [Abstract][Full Text] [Related]
60. β-Arrestins in the immune system.
Jiang D; Xie T; Liang J; Noble PW
Prog Mol Biol Transl Sci; 2013; 118():359-93. PubMed ID: 23764061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
